Ragweed allergy vaccine sublingual - Lofarma SpA

Drug Profile

Ragweed allergy vaccine sublingual - Lofarma SpA

Alternative Names: Lais Ambrosia

Latest Information Update: 26 Feb 2016

Price : $50

At a glance

  • Originator Lofarma S.p.A
  • Class Allergens; Antiallergics; Plant allergy immunotherapies
  • Mechanism of Action Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase II Seasonal allergic rhinitis

Most Recent Events

  • 06 May 2012 Phase-II clinical trials in Seasonal allergic rhinitis in Italy (Sublingual)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top